Discovery of an allosteric, potent and selective DHX9 helicase inhibitor with best-in-class potential for the treatment of genomically unstable cancers

Taran Khanam, Helen Harrison, Peter Astles, Harry Wing, Rita Chaouni, Roxine Staats, Tamsin Samuels, Richard Fosbeary, Natalie Webster, Angela Shibu, Giles Pergl-Wilson, Elizabeth Anderson, Beth Thomas, Oliver Rausch

STORM Therapeutics Limited, Babraham Research Campus, Cambridge, United Kingdom

Download poster